Home
Scholarly Works
Expanded phase I study of vorinostat (VOR) in...
Conference

Expanded phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors

Authors

Townsley C; Oza AM; Tang P; Siu LL; Pond GR; Sarveswaran P; Webster S; Zwiebel JA; Chen EX

Volume

26

Pagination

pp. 11096-11096

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

May 20, 2008

DOI

10.1200/jco.2008.26.15_suppl.11096

Conference proceedings

Journal of Clinical Oncology

Issue

15_suppl

ISSN

0732-183X
View published work (Non-McMaster Users)

Contact the Experts team